The prognostic significance of B lymphocytes in invasive carcinoma of the breast. (Q42489904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

The prognostic significance of B lymphocytes in invasive carcinoma of the breast (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Ian Ellis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Andrew Green

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

A H S Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

E C Paish

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

R D Macmillan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

14 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

545-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-011-1620-1

4 February 2020

exact match

0 references

cites work

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Malignancy and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Angiogenesis and inflammation in invasive carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

CD20: a regulator of cell-cycle progression of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

The biology of CD20 and its potential as a target for mAb therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Validation of tissue microarray technology in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Expression of BRCA1 protein in breast cancer and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas--correlation with tumour differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Immunological enhancement of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Patterns of Human Tumor-Infiltrating Lymphocytes in 120 Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Naturally occurring B-cell responses to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1620-1

10.1007/S10549-011-1620-1

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671016%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 February 2020

0 references

1 reference